Canton Hathaway’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Canton Hathaway's ELV Position: Q3 2022 in Review
Canton Hathaway sold out of Elevance Health (ELV) in Q3 2022, closing a stake of 74 shares — an estimated $36K sold.
Canton Hathaway first reported a position in ELV in Q3 2021 and held it in 4 quarters. The position peaked at $36K in Q2 2022. 1,445 funds tracked by Wall St. Rank hold ELV as of Q3 2022.
- Canton Hathaway reported no remaining Elevance Health position as of Q3 2022 after selling out during the quarter.
- Canton Hathaway sold 74 Elevance Health shares in Q3 2022, an estimated $36K.
- Canton Hathaway first reported a position in Elevance Health in Q3 2021 and held it in 4 quarters.
- Canton Hathaway's Elevance Health position peaked at $36K in Q2 2022.
- 1,445 funds tracked by Wall St. Rank held Elevance Health as of Q3 2022.
Based on Canton Hathaway's 13F filing for Q3 2022, filed 17 Oct 2022.